Bioniche Life Sciences Inc. has received a notice of compliance from Health Canada's Veterinary Drugs Directorate for a low molecular weight hyaluronate sodium product for horses.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In